Novan, Inc. (NOVN)
| Market Cap | 138.84M |
| Revenue (ttm) | 3.95M |
| Net Income (ttm) | -30.02M |
| Shares Out | 15.57M |
| EPS (ttm) | -2.06 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 222,018 |
| Open | 7.30 |
| Previous Close | 7.38 |
| Day's Range | 7.07 - 7.30 |
| 52-Week Range | 4.35 - 25.90 |
| Beta | 0.07 |
| Analysts | Buy |
| Price Target | 36.40 (+401.4%) |
| Est. Earnings Date | Oct 28, 2021 |
About NOVN
Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-base...
Financial Performance
In 2020, Novan's revenue was $4.92 million, an increase of 0.49% compared to the previous year's $4.90 million. Losses were -$29.29 million, -3.57% less than in 2019.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for Novan stock is "Buy" and the 12-month stock price forecast is 36.40.
News
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
– SB206 demonstrates continued favorable safety profile consistent with previous studies and meets Company's expectations –
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
– Live fireside chat with Paula Brown Stafford, President and Chief Executive Officer of Novan on Tuesday, September 28 at 8:00 AM ET – – Live fireside chat with Paula Brown Stafford, President and Chie...
Novan Announces Strategic Priorities and Outlines Key Milestones
– Company planning for three potential New Drug Application (NDA) filings in three years with the first submission expected in Q3 2022 for lead program SB206 in molluscum contagiosum –
Novan Engages Syneos Health as Commercial Solutions Provider for SB206
– Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy results from a pivotal Phase 3 B-SIMPLE4 trial in patients...
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
DURHAM, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will pa...
Novan to Host Corporate Update Conference Call and Webcast on September 9, 2021
– Conference call with live audio webcast to be held on Thursday, September 9 th at 8:30 a.m. ET –
Novan Reports Second Quarter 2021 Financial Results and Provides Corporate Update
– Positive data across all three of the Company's priority pipeline development programs, announced in Q2 2021, further validating the potential of its novel, proprietary NITRICIL™ technology –
How to Pick the Best Small Cap Biotech Stocks to Buy
Investing in biotech stocks isn't for the faint of heart, but these can be some of the most lucrative equities on the market. The post How to Pick the Best Small Cap Biotech Stocks to Buy appeared first...
Novan to Report Second Quarter 2021 Financial Results on August 12, 2021
Company to host conference call and webcast on Thursday, August 12, 2021, at 8:30 a.m. ET Company to host conference call and webcast on Thursday, August 12, 2021, at 8:30 a.m. ET
Novan Announces Last Patient Visit at Week 24 in B-SIMPLE4 Pivotal Phase 3 Trial of SB206 in Patients with Molluscum ...
– Company previously reported positive topline efficacy and favorable safety data at Week 12 from B-SIMPLE4 in June 2021, with primary endpoint achieving statistical significance with p-value less than ...
Pritzker Private Capital Appoints Paula Brown Stafford to Pritzker Advisory Board
CHICAGO--(BUSINESS WIRE)--Pritzker Private Capital (“PPC”), a leader in family direct investing, today announced the appointment of Paula Brown Stafford to the Pritzker Advisory Board. Ms. Stafford, cur...
Novan Announces Inclusion in Russell Microcap® Index
DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that as part of the annual reconstitution of the Russell stock indexes, Novan has b...
Novan Announces Closing of $40 Million Public Offering of Common Stock
DURHAM, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (the “Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company's previously announced underwritten public offering (the “...
Novan Stock Falls After Raising $40M Via Equity At 21% Discount
Novan Inc (NASDAQ: NOVN) priced its previously announced public offering of 3.6 million shares at $11/share for gross proceeds of approximately $40 million. The offer price represents a 21% discount on ...
Novan Announces Pricing of $40 Million Public Offering of Common Stock
DURHAM, N.C., June 17, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (the “Company" or "Novan") (NASDAQ:NOVN) today announced the pricing of the Company's previously announced underwritten public offering (the “...
Novan Announces Proposed Public Offering of Common Stock
DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (the “Company” or “Novan”) (NASDAQ: NOVN) today announced a proposed underwritten public offering of its common stock (the “Offering”). All sh...
4 Penny Stocks To Watch Hit It Big In 2021, 1 Up Over 2,200% Right Now
Are these former penny stocks on your watch list right now? The post 4 Penny Stocks To Watch Hit It Big In 2021, 1 Up Over 2,200% Right Now appeared first on Penny Stocks to Buy, Picks, News and Informa...
NOVN Stock: The Positive Trial Results Sending Novan Skyrocketing Today
NOVN stock is flexing 70% gains as the company shows off the wild success of its topical treatment for a common, contagious infection. The post NOVN Stock: The Positive Trial Results Sending Novan Skyro...
A Technical Look At Novan's Stock Amid 80% Spike
Novan Inc. (NASDAQ: NOVN) shares are trading higher Friday after the company reported that B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved significance for the primary endpoint with no adverse events....
Why Novan Shares Are Surging Today
Novan Inc (NASDAQ:NOVN) shares are trading higher by 59% at $14.37 Friday morning after the company reported the B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved statistical significance for the primar...
Novan's Stock Surges As SB206 Can Potentially Shorten Duration Of Contagious Skin Disease
Novan Inc (NASDAQ: NOVN) has announced positive topline efficacy and safety results from the B-SIMPLE4 Phase 3 trial evaluating SB206, a topical antiviral gel, for the treatment of molluscum contagiosum...
Novan Reports Positive Topline Results from Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
– B-SIMPLE4 achieves statistical significance for the primary endpoint with p-value less than 0.0001 –
Novan Announces Positive Preclinical Data in SB019 COVID-19 Anti-Viral Therapy Program
– Data indicate that berdazimer sodium prevents progression of SARS-CoV-2 infection in two independent in vivo transmission studies –
Results from Novan's Exploratory Studies Further Demonstrate Antimicrobial Effect of NITRICIL™ Platform Technology wi...
– Positive in vitro results demonstrate antimicrobial effect of NVN4100 against a wide variety of bacteria and suggest a promising bactericidal mode of action –
Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May
Biotech penny stocks are heating up right now; here's 4 to watch The post Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May appeared first on Penny Stocks to Buy, Picks, News and Informat...